about
Progress and perspectives on targeting nanoparticles for brain drug delivery.Progress on the diagnosis and evaluation of brain tumors.Lapatinib-incorporated lipoprotein-like nanoparticles: preparation and a proposed breast cancer-targeting mechanism.Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles.Polyethylene glycol modification decreases the cardiac toxicity of carbonaceous dots in mouse and zebrafish models.Utilizing G2/M retention effect to enhance tumor accumulation of active targeting nanoparticles.Pretreatment with chemotherapeutics for enhanced nanoparticles accumulation in tumor: the potential role of G2 cycle retention effect.Effect of lactoferrin- and transferrin-conjugated polymersomes in brain targeting: in vitro and in vivo evaluations.Targeted delivery of nano-therapeutics for major disorders of the central nervous system.The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior.Cell-penetrating peptide-based intelligent liposomal systems for enhanced drug delivery.Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.Melanin-originated carbonaceous dots for triple negative breast cancer diagnosis by fluorescence and photoacoustic dual-mode imaging.A simple one-step synthesis of melanin-originated red shift emissive carbonaceous dots for bioimaging.A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan.A Novel Strategy through Combining iRGD Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration.Noninvasive In Vivo Diagnosis of Brain Glioma Using RGD-Decorated Fluorescent Carbonaceous Nanospheres.Preparation,-Characterization and Anti-Glioma Effects of Docetaxel-Incorporated Albumin-Lipid Nanoparticles.Self-Targeting Fluorescent Carbon Dots for Diagnosis of Brain Cancer Cells.Perspectives on Dual Targeting Delivery Systems for Brain Tumors.Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.Shaping Tumor Microenvironment for Improving Nanoparticle Delivery.Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating.Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.Preparation and biological evaluation of photoluminescent carbonaceous nanospheres.PEGylated fluorescent carbon nanoparticles for noninvasive heart imaging.A simple one-step method for preparation of fluorescent carbon nanospheres and the potential application in cell organelles imaging.In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles.In vivo behavior and safety of lapatinib-incorporated lipid nanoparticles.Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery.Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.Rubik-like magnetic nanoassemblies as an efficient drug multifunctional carrier for cancer theranostics.Glioma targeting and anti-glioma effect of interleukin 13 peptide and RGD peptide dual functionalized nanoparticles.Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles.Matrix metalloproteases-responsive nanomaterials for tumor targeting diagnosis and treatment.The use of myristic acid as a ligand of polyethylenimine/DNA nanoparticles for targeted gene therapy of glioblastoma.Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays.Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
P50
Q26740580-8E2F92EB-DDCF-4321-9943-90DD5433F9C0Q30714285-FC505ACD-C827-4EF1-9D9C-8FE0F4A63821Q33861915-A8775A66-5606-425C-8A52-9E7DFA736FB4Q34444167-7558ECCB-8E52-404B-8C88-66DD46F11D99Q35803036-AD77454B-50CB-4D66-9265-C9C05E4372BBQ36980441-7C5CECA8-C2C3-4C97-AC66-AC6D1AEDFA3EQ37666715-9B072B8B-0DE8-4493-86AE-1A64A34E93ACQ37728982-B37A3AF1-43C0-4388-804E-B5546D1EC3F9Q38116765-B6203C84-5227-49B7-A3E3-DD93EDF22030Q38176391-89B323D7-E5E2-4845-BF0E-A1ECB61C1610Q38221050-1D038D47-BB2D-45B2-9668-15F763139920Q38684280-7E02B2CE-93A9-4AF4-8368-38E91594E4FCQ38712599-06733681-6A38-40AA-92E6-A3F1049848DDQ38758208-1C51C238-E874-47A2-AEF2-72893E5D1CFEQ38811338-B0833239-6268-4338-A282-37D0DCC48449Q38814620-CF9847CB-BD19-4716-9F8C-DBC33D4F91D6Q38824195-1700CAF0-CE1A-43AC-9A1C-9037C62CCF12Q38824199-5D7429C1-3C42-49FC-8C34-ED3E803427C2Q38828659-B476CF97-E093-418F-A03E-DFE27C7959F1Q38857119-47DDCC4B-F938-44D2-9B19-DCF777A6478DQ38882705-90CBAEB0-8E45-49B6-B8D6-B946A31CEE31Q38891436-23FFAA0D-BD54-47D1-861A-4774DA923642Q38935178-6913B014-13FB-4FA1-9888-04E2C614F54DQ38964575-57931ACA-B052-4E72-913A-83BE47AC4F9BQ38979108-DA625F76-BCB5-4FBD-8954-1C12A1B6DBD2Q38984131-E0723BB7-5433-4B8D-9B51-53FAFDF193F1Q38992746-8C5CE590-E107-45F3-A3EA-9346C588FA9DQ39013194-C8C7A920-A995-45CE-9FD6-E0AB79AA5577Q39017509-62850731-7A65-46F8-96DD-596F7B0E3619Q39025424-470E468E-CA9B-4FCB-84D5-C370AE66C579Q39033881-BB91C803-B519-4B64-948F-CC992FD74C56Q39036112-598A0E79-40CB-4240-A0FD-16394A2B2E88Q39080267-3984763F-18DD-4EF7-B21A-CA2ED7D80615Q39085839-52D1C370-5F8A-4DCF-9EC2-7F3C8D26D7CAQ39098383-CCAA2C5D-9E25-407A-9C02-4B6042D081F4Q39368150-540288D3-CAF1-475F-AF0B-5A8A3CB37C16Q39375298-A5574861-7A2B-4BDF-9F1B-3C572A694C4FQ39466558-A5F40021-7210-44FD-B54E-815E42175DAEQ46375000-8A390AB9-F469-41CB-8F15-89F9B6D46425Q47386579-26775B38-2482-45A4-8EE9-0A73DEC029A9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Huile Gao
@ast
Huile Gao
@en
Huile Gao
@es
Huile Gao
@nl
type
label
Huile Gao
@ast
Huile Gao
@en
Huile Gao
@es
Huile Gao
@nl
prefLabel
Huile Gao
@ast
Huile Gao
@en
Huile Gao
@es
Huile Gao
@nl
P106
P31
P496
0000-0002-5355-7238